• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?抗磷脂综合征中的标准与非标准抗磷脂抗体:它们的相关性有多强?
Biomedicines. 2023 Aug 3;11(8):2192. doi: 10.3390/biomedicines11082192.
2
"Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort."非标准"抗磷脂抗体在一个大型中国队列中增加了抗磷脂综合征诊断的价值。
Arthritis Res Ther. 2020 Feb 21;22(1):33. doi: 10.1186/s13075-020-2131-4.
3
Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss.非自愿体重减轻患者中抗磷脂抗体与癌症的标准及非标准情况
J Pers Med. 2023 Oct 29;13(11):1549. doi: 10.3390/jpm13111549.
4
Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added.抗磷脂综合征中的非标准抗磷脂抗体:诊断价值增加。
Front Immunol. 2022 Oct 26;13:972012. doi: 10.3389/fimmu.2022.972012. eCollection 2022.
5
Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients.中国患者抗磷脂抗体综合征中非标准抗磷脂抗体的流行情况及诊断价值。
Front Immunol. 2023 Apr 12;14:1107510. doi: 10.3389/fimmu.2023.1107510. eCollection 2023.
6
Clinical performance of non-criteria antibodies to phospholipids in Chinese patients with antiphospholipid syndrome.抗磷脂抗体谱非标准抗体在我国抗磷脂综合征患者中的临床表现。
Clin Chim Acta. 2019 Aug;495:205-209. doi: 10.1016/j.cca.2019.04.065. Epub 2019 Apr 16.
7
Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome.标准和非标准抗磷脂自身抗体的谱与抗磷脂综合征的临床表型相关。
Auto Immun Highlights. 2020 May 15;11(1):8. doi: 10.1186/s13317-020-00131-3. eCollection 2020 Dec.
8
Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort.评价非标准抗体对中国人群抗磷脂综合征患者的诊断价值。
Front Immunol. 2021 Sep 10;12:741369. doi: 10.3389/fimmu.2021.741369. eCollection 2021.
9
Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.小血管脑病变且有抗磷脂综合征相关临床表现患者的额外标准抗磷脂抗体
J Stroke Cerebrovasc Dis. 2023 May;32(5):107034. doi: 10.1016/j.jstrokecerebrovasdis.2023.107034. Epub 2023 Feb 25.
10
[Value of IgA antiphospholipid antibodies in diagnosis of the antiphospholipid syndrome].[IgA抗磷脂抗体在抗磷脂综合征诊断中的价值]
Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3404-3410. doi: 10.3760/cma.j.cn112137-20210424-00976.

引用本文的文献

1
Antiphospholipid antibodies in patients with COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎患者的抗磷脂抗体:一项系统评价与荟萃分析
J Thromb Thrombolysis. 2025 Jul 5. doi: 10.1007/s11239-025-03116-z.
2
Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices.灾难性抗磷脂综合征:当前证据与未来管理实践综述
Cureus. 2024 Sep 19;16(9):e69730. doi: 10.7759/cureus.69730. eCollection 2024 Sep.
3
Antiphospholipid Antibody Testing: An Audit on Testing Practices in a Public Tertiary Care Center.抗磷脂抗体检测:对一家公立三级医疗中心检测实践的审计
J Clin Med. 2023 Dec 31;13(1):243. doi: 10.3390/jcm13010243.
4
Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss.非自愿体重减轻患者中抗磷脂抗体与癌症的标准及非标准情况
J Pers Med. 2023 Oct 29;13(11):1549. doi: 10.3390/jpm13111549.

本文引用的文献

1
Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.抗磷脂抗体综合征与系统性红斑狼疮患者中非标准抗磷脂抗体滴度的相关性。
Reumatol Clin (Engl Ed). 2023 Apr;19(4):197-203. doi: 10.1016/j.reumae.2023.01.001.
2
The history of antiphospholipid syndrome.抗磷脂综合征的历史。
Reumatismo. 2023 Mar 21;74(4). doi: 10.4081/reumatismo.2022.1556.
3
Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added.抗磷脂综合征中的非标准抗磷脂抗体:诊断价值增加。
Front Immunol. 2022 Oct 26;13:972012. doi: 10.3389/fimmu.2022.972012. eCollection 2022.
4
Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome-Single Centre Observational Study in the United Kingdom.抗磷脂综合征患者中抗PS/PT抗体的频率及临床意义——英国单中心观察性研究
Semin Thromb Hemost. 2023 Jul;49(5):553-557. doi: 10.1055/s-0042-1757633. Epub 2022 Nov 1.
5
Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis.抗磷脂综合征患者中 Phosphatidylserine/prothrombin 抗体的流行情况及其与抗磷脂抗体谱的关系:系统评价和荟萃分析。
Thromb Res. 2022 Jun;214:106-114. doi: 10.1016/j.thromres.2022.04.021. Epub 2022 May 2.
6
Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up.原发性抗磷脂综合征的复发性血栓形成模式:多中心、真实世界的长期随访。
Front Immunol. 2022 Apr 19;13:843718. doi: 10.3389/fimmu.2022.843718. eCollection 2022.
7
The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.抗磷脂综合征的病理生理学:来自血液凝固系统的视角
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221088576. doi: 10.1177/10760296221088576.
8
Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort.评价非标准抗体对中国人群抗磷脂综合征患者的诊断价值。
Front Immunol. 2021 Sep 10;12:741369. doi: 10.3389/fimmu.2021.741369. eCollection 2021.
9
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.国际血栓与止血学会狼疮抗凝物/抗磷脂抗体科学与标准化委员会的指南:狼疮抗凝物检测和解释指南的更新。
J Thromb Haemost. 2020 Nov;18(11):2828-2839. doi: 10.1111/jth.15047.
10
Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action.抗β2糖蛋白I抗体和抗凝血酶原抗体通过不同作用机制导致狼疮抗凝物产生。
J Thromb Haemost. 2021 Apr;19(4):1018-1028. doi: 10.1111/jth.15241. Epub 2021 Feb 9.

抗磷脂综合征中的标准与非标准抗磷脂抗体:它们的相关性有多强?

Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?

作者信息

Caraiola Simona, Voicu Laura, Jurcut Ciprian, Dima Alina, Baicus Cristian, Baicus Anda, Cobilinschi Claudia Oana, Ionescu Razvan Adrian

机构信息

Fifth Department-Internal Medicine (Cardiology, Gastroenterology, Hepatology, Rheumatology, Geriatrics), Family Medicine, Occupational Medicine, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Internal Medicine Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.

出版信息

Biomedicines. 2023 Aug 3;11(8):2192. doi: 10.3390/biomedicines11082192.

DOI:10.3390/biomedicines11082192
PMID:37626689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10452164/
Abstract

The place of non-criteria antiphospholipid antibodies (aPLs) in the diagnosis of antiphospholipid syndrome (APS) is still debatable. The aim of this research was to evaluate the correlations between the titres of non-criteria aPLs (anti-phosphatidylethanolamine (aPE), anti-phosphatidylserine (aPS), and anti-prothrombin (aPT) antibodies), and the ones of the already studied criteria aPLs (anti-cardiolipin (aCL) and anti-β2 glycoprotein I-aβ2GPI antibodies). Altogether, 72 APS (30 primary and 42 secondary) patients were included in our study. High correlation coefficients (rs) were found between aPS IgM and aCL IgM, overall (0.77, < 0.01), as well as in the primary (0.81, < 0.01), and secondary (0.75, < 0.01) APS subgroups. Low or statistically insignificant correlations were observed between IgG/IgM isotypes of aPT and aCL, or aβ2GPI, in the entire study population, and when evaluating the subgroups. Therefore, moderate correlations were mainly identified between the tested non-criteria antibodies and the criteria ones, suggesting little added value for the use of the tested non-criteria aPLs, with the exception of aPT, which seems to have different kinetics and might be a promising APS diagnostic tool.

摘要

非标准抗磷脂抗体(aPLs)在抗磷脂综合征(APS)诊断中的地位仍存在争议。本研究的目的是评估非标准aPLs(抗磷脂酰乙醇胺(aPE)、抗磷脂酰丝氨酸(aPS)和抗凝血酶原(aPT)抗体)的滴度与已研究的标准aPLs(抗心磷脂(aCL)和抗β2糖蛋白I-aβ2GPI抗体)滴度之间的相关性。本研究共纳入72例APS患者(30例原发性和42例继发性)。总体上,aPS IgM与aCL IgM之间发现高相关系数(rs)(0.77,<0.01),在原发性APS亚组(0.81,<0.01)和继发性APS亚组(0.75,<0.01)中也是如此。在整个研究人群中以及评估亚组时,观察到aPT与aCL或aβ2GPI的IgG/IgM同种型之间存在低相关性或无统计学意义的相关性。因此,在测试的非标准抗体与标准抗体之间主要发现了中等相关性,这表明除aPT外,测试的非标准aPLs的使用价值不大,aPT似乎具有不同的动力学,可能是一种有前景的APS诊断工具。